Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation
EXPERT OPINION ON BIOLOGICAL THERAPY, cilt.15, sa.2, ss.195-211, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 15 Sayı: 2
- Basım Tarihi: 2015
- Doi Numarası: 10.1517/14712598.2015.971749
- Dergi Adı: EXPERT OPINION ON BIOLOGICAL THERAPY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.195-211
- Anahtar Kelimeler: allogeneic hematopoietic stem cell transplant, autologous hematopoietic stem cell transplant, erythropoiesis-stimulating agents, erythropoietin, RECOMBINANT-HUMAN-ERYTHROPOIETIN, BONE-MARROW-TRANSPLANTATION, QUALITY-OF-LIFE, CLINICAL-PRACTICE GUIDELINE, CHEMOTHERAPY-INDUCED ANEMIA, EPOETIN-ALPHA, CANCER-PATIENTS, PERIPHERAL-BLOOD, DARBEPOETIN-ALPHA, INTRAVENOUS IRON
- Ankara Üniversitesi Adresli: Evet
Özet
Introduction: Erythropoiesis-stimulating agents (ESAs) are used in treating cancer- and chemotherapy-induced anemia with the aim of accelerating the recovery of red blood cells (RBCs), reduce the risks associated with RBC transfusions and improve quality of life.